Abstract
Scientists have tried for many years to understand cancer development and progression in the expectation of defining the therapeutic target. Emerging evidence has revealed that cancers contain a minority population, termed “Cancer stem cells (CSCs)”, which are responsible for sustaining the tumour as well as giving rise to proliferating cells. CSCs are thought share the three features with normal stem cells: self-renewal, the capability give rise to multiple lineages, the potential to proliferate extensively and therefore it has been proposed that they have their origin in normal stem cells. However, since there is evidence that genetic alterations occurring in committed progenitor cells can reactive their proliferative potential, the origin of CSCs still remains undecided. In this review, we discuss the current status of cancer stem cells in various tissues, the origin of some cancers from normal stem cells, the evidence for the existence of particular markers and aspects of their cell biology. Better understanding of the relation between adult stem cells and cancer stem cells in tumourigenesis may will provide novel therapeutic strategies against cancers.
Keywords: Stem cells, cancer stem cells, side population (SP), non-SP, tumourigenesis, mitochondria
Current Cancer Therapy Reviews
Title: Cancer and Stem Cells
Volume: 4 Issue: 3
Author(s): Lydia Gutierrez-Gonzalez, Osamu Inatomi, Julia Burkert and Nichoals A. Wright
Affiliation:
Keywords: Stem cells, cancer stem cells, side population (SP), non-SP, tumourigenesis, mitochondria
Abstract: Scientists have tried for many years to understand cancer development and progression in the expectation of defining the therapeutic target. Emerging evidence has revealed that cancers contain a minority population, termed “Cancer stem cells (CSCs)”, which are responsible for sustaining the tumour as well as giving rise to proliferating cells. CSCs are thought share the three features with normal stem cells: self-renewal, the capability give rise to multiple lineages, the potential to proliferate extensively and therefore it has been proposed that they have their origin in normal stem cells. However, since there is evidence that genetic alterations occurring in committed progenitor cells can reactive their proliferative potential, the origin of CSCs still remains undecided. In this review, we discuss the current status of cancer stem cells in various tissues, the origin of some cancers from normal stem cells, the evidence for the existence of particular markers and aspects of their cell biology. Better understanding of the relation between adult stem cells and cancer stem cells in tumourigenesis may will provide novel therapeutic strategies against cancers.
Export Options
About this article
Cite this article as:
Gutierrez-Gonzalez Lydia, Inatomi Osamu, Burkert Julia and Wright A. Nichoals, Cancer and Stem Cells, Current Cancer Therapy Reviews 2008; 4 (3) . https://dx.doi.org/10.2174/157339408785294249
DOI https://dx.doi.org/10.2174/157339408785294249 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma
Current Cancer Drug Targets Computed Tomographic Evaluation of Colonic Diverticulum Complications
Current Medical Imaging Exploring the Role of Nerve Growth Factor in Multiple Sclerosis: Implications in Myelin Repair
CNS & Neurological Disorders - Drug Targets Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors
Current Cancer Drug Targets Empagliflozin and the Diabetic Kidney: Pathophysiological Concepts and Future Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & Therapy The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Current Cancer Drug Targets Effect of Environmental Substances on the Activity of Arylamine N-Acetyltransferases
Current Drug Metabolism Structural Magnetic Resonance Imaging Findings in Posttraumatic Stress Disorder and Their Response to Treatment: A Systematic Review
Current Psychiatry Reviews Role of Kynurenines in the Central and Peripherial Nervous Systems
Current Neurovascular Research Therapeutic Potential of γ -Secretase Inhibitors and Modulators
Current Topics in Medicinal Chemistry Therapeutic Strategies to Target Multiple Kinases in Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Mechanistic Insights into the Antileukemic Activity of Hyperforin
Current Cancer Drug Targets Roles of miRNA in the Initiation and Development of Colorectal Carcinoma
Current Pharmaceutical Design Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Novel 1,3,4-Triaryl Pyrazoles: Synthesis, QSAR Studies and Cytotoxicity against Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry The Role of Dietary Approach in Irritable Bowel Syndrome
Current Medicinal Chemistry Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents
Recent Patents on Anti-Cancer Drug Discovery The Use of Lentinan for Treating Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry